Update: 27.08.2024
Last week: 33 week 2024 (12.08.2024 - 18.08.2024)
Last full month: July 2024
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | |||||||||
| WoW | 7 854 | -0.1% | 13.5% | -0.6 | 14 655 686 | -2.4% | 9.5% | -0.7 | 4.4% |
| MoM | 33 561 | 12.5% | 13.2% | 1.4 | 64 687 077 | 4.5% | 9.7% | 0.5 | 0.2% |
| YTD | 240 080 | 20.4% | 11.6% | 2.8 | 513 053 902 | 39.0% | 9.4% | 2 | -8.3% |
| MAT | 381 502 | 24.4% | 10.8% | 2.1 | 800 719 830 | 42.1% | 8.9% | 1.6 | -0.0% |
| BRAINMAX | |||||||||
| WoW | 1 295 | -8.2% | 100.0% | 0 | 4 857 248 | -14.0% | 100.0% | 0 | -8.2% |
| MoM | 5 212 | 11.0% | 100.0% | 0 | 19 612 893 | 12.5% | 100.0% | 0 | 11.2% |
| YTD | 35 383 | 39.6% | 100.0% | 0 | 130 044 443 | 51.5% | 100.0% | 0 | 39.6% |
| MAT | 56 687 | 60.7% | 100.0% | 0 | 205 222 182 | 74.4% | 100.0% | 0 | 60.7% |
| GOLDLINE PLUS | |||||||||
| WoW | 15 328 | 6.6% | 45.9% | 0.6 | 47 498 585 | 7.4% | 38.2% | 1.2 | 5.2% |
| MoM | 68 010 | -10.6% | 46.4% | 0.7 | 212 403 736 | -10.0% | 38.3% | 0.8 | -12.0% |
| YTD | 554 834 | -4.8% | 45.0% | 0.8 | 1 746 887 178 | -1.7% | 36.8% | -2.7 | -6.4% |
| MAT | 841 036 | 1.8% | 45.5% | 1 | 2 661 090 079 | 7.6% | 37.9% | -1.6 | -0.4% |
| MIGRENIUM | |||||||||
| WoW | 12 146 | -2.1% | 0.5% | 0 | 4 045 418 | -1.9% | 0.7% | -0.1 | 6.2% |
| MoM | 45 770 | -3.4% | 0.5% | -0.1 | 15 433 925 | -1.3% | 0.6% | -0.1 | 11.3% |
| YTD | 387 752 | -7.7% | 0.5% | -0.1 | 120 318 136 | 57.6% | 0.7% | 0.2 | 8.2% |
| MAT | 609 399 | -7.4% | 0.5% | -0.1 | 166 628 423 | 39.3% | 0.6% | 0.1 | 11.6% |
| MODELAX-N | |||||||||
| WoW | 24 706 | 0.7% | 19.9% | -0.7 | 11 610 436 | 1.2% | 13.1% | -0.5 | 4.2% |
| MoM | 102 999 | -20.7% | 19.3% | -6.2 | 48 116 412 | -16.9% | 13.0% | -4 | 4.9% |
| YTD | 959 788 | 33.3% | 22.8% | 4.1 | 414 196 373 | 82.6% | 14.7% | 4.3 | 9.2% |
| MAT | 1 407 562 | 53.4% | 21.2% | 5.3 | 570 131 103 | 94.1% | 13.1% | 4.1 | 15.1% |
| REDUXIN | |||||||||
| WoW | 10 816 | 3.7% | 32.4% | -0.5 | 54 858 183 | 4.0% | 44.1% | -0.1 | 5.2% |
| MoM | 48 170 | -9.4% | 32.8% | 1 | 247 736 086 | -11.8% | 44.6% | 0.1 | -12.0% |
| YTD | 405 915 | -8.7% | 32.9% | -0.8 | 2 169 789 016 | 13.3% | 45.7% | 3.2 | -6.4% |
| MAT | 599 171 | -5.1% | 32.4% | -1.6 | 3 128 460 735 | 17.0% | 44.5% | 1.8 | -0.4% |
| REDUXIN FORTE | |||||||||
| WoW | 3 091 | -6.7% | 9.2% | -1.2 | 12 817 745 | -9.9% | 10.3% | -1.6 | 5.2% |
| MoM | 13 691 | -8.3% | 9.3% | 0.4 | 57 980 483 | -10.1% | 10.4% | 0.2 | -12.0% |
| YTD | 109 236 | -0.2% | 8.9% | 0.6 | 472 713 653 | 13.1% | 10.0% | 0.7 | -6.4% |
| MAT | 165 821 | 9.7% | 9.0% | 0.8 | 708 256 374 | 22.2% | 10.1% | 0.8 | -0.4% |
| SALVISAR | |||||||||
| WoW | 9 211 | 11.2% | 1.2% | 0.1 | 3 913 085 | 9.5% | 1.1% | 0 | 6.2% |
| MoM | 34 936 | -11.1% | 1.1% | -0.2 | 15 667 203 | -7.6% | 1.1% | -0.1 | 2.1% |
| YTD | 328 431 | 1.8% | 1.3% | 0 | 133 919 656 | 27.4% | 1.2% | 0.1 | -1.7% |
| MAT | 504 321 | -11.2% | 1.3% | -0.2 | 192 552 048 | 1.0% | 1.1% | -0.2 | 2.6% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 240 080 | 20.4% | 11.6% | 2.8 | 513 053 902 | 39.0% | 9.4% | 2 | -8.3% |
| BRAINMAX | 35 383 | 39.6% | 100.0% | 0 | 130 044 443 | 51.5% | 100.0% | 0 | 39.6% |
| GOLDLINE PLUS | 554 834 | -4.8% | 45.0% | 0.8 | 1 746 887 178 | -1.7% | 36.8% | -2.7 | -6.4% |
| MIGRENIUM | 387 752 | -7.7% | 0.5% | -0.1 | 120 318 136 | 57.6% | 0.7% | 0.2 | 8.2% |
| MODELAX-N | 959 788 | 33.3% | 22.8% | 4.1 | 414 196 373 | 82.6% | 14.7% | 4.3 | 9.2% |
| REDUXIN CAPS | 405 915 | -8.7% | 32.9% | -0.8 | 2 169 789 016 | 13.3% | 45.7% | 3.2 | -6.4% |
| REDUXIN FORTE | 109 236 | -0.2% | 8.9% | 0.6 | 472 713 653 | 13.1% | 10.0% | 0.7 | -6.4% |
| SALVISAR | 328 431 | 1.8% | 1.3% | 0 | 133 919 656 | 27.4% | 1.2% | 0.1 | -1.7% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 381 502 | 24.4% | 10.8% | 2.1 | 800 719 830 | 42.1% | 8.9% | 1.6 | -0.0% |
| BRAINMAX | 56 687 | 60.7% | 100.0% | 0 | 205 222 182 | 74.4% | 100.0% | 0 | 60.7% |
| GOLDLINE PLUS | 841 036 | 1.8% | 45.5% | 1 | 2 661 090 079 | 7.6% | 37.9% | -1.6 | -0.4% |
| MIGRENIUM | 609 399 | -7.4% | 0.5% | -0.1 | 166 628 423 | 39.3% | 0.6% | 0.1 | 11.6% |
| MODELAX-N | 1 407 562 | 53.4% | 21.2% | 5.3 | 570 131 103 | 94.1% | 13.1% | 4.1 | 15.1% |
| REDUXIN CAPS | 599 171 | -5.1% | 32.4% | -1.6 | 3 128 460 735 | 17.0% | 44.5% | 1.8 | -0.4% |
| REDUXIN FORTE | 165 821 | 9.7% | 9.0% | 0.8 | 708 256 374 | 22.2% | 10.1% | 0.8 | -0.4% |
| SALVISAR | 504 321 | -11.2% | 1.3% | -0.2 | 192 552 048 | 1.0% | 1.1% | -0.2 | 2.6% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 7 854 | -0.1% | 13.5% | -0.6 | 14 655 686 | -2.4% | 9.5% | -0.7 | 4.4% |
| BRAINMAX | 1 295 | -8.2% | 100.0% | 0 | 4 857 248 | -14.0% | 100.0% | 0 | -8.2% |
| GOLDLINE PLUS | 15 328 | 6.6% | 45.9% | 0.6 | 47 498 585 | 7.4% | 38.2% | 1.2 | 5.2% |
| MIGRENIUM | 12 146 | -2.1% | 0.5% | 0 | 4 045 418 | -1.9% | 0.7% | -0.1 | 6.2% |
| MODELAX-N | 24 706 | 0.7% | 19.9% | -0.7 | 11 610 436 | 1.2% | 13.1% | -0.5 | 4.2% |
| REDUXIN CAPS | 10 816 | 3.7% | 32.4% | -0.5 | 54 858 183 | 4.0% | 44.1% | -0.1 | 5.2% |
| REDUXIN FORTE | 3 091 | -6.7% | 9.2% | -1.2 | 12 817 745 | -9.9% | 10.3% | -1.6 | 5.2% |
| SALVISAR | 9 211 | 11.2% | 1.2% | 0.1 | 3 913 085 | 9.5% | 1.1% | 0 | 6.2% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 33 561 | 12.5% | 13.2% | 1.4 | 64 687 077 | 4.5% | 9.7% | 0.5 | 0.2% |
| BRAINMAX | 5 212 | 11.0% | 100.0% | 0 | 19 612 893 | 12.5% | 100.0% | 0 | 11.2% |
| GOLDLINE PLUS | 68 010 | -10.6% | 46.4% | 0.7 | 212 403 736 | -10.0% | 38.3% | 0.8 | -12.0% |
| MIGRENIUM | 45 770 | -3.4% | 0.5% | -0.1 | 15 433 925 | -1.3% | 0.6% | -0.1 | 11.3% |
| MODELAX-N | 102 999 | -20.7% | 19.3% | -6.2 | 48 116 412 | -16.9% | 13.0% | -4 | 4.9% |
| REDUXIN CAPS | 48 170 | -9.4% | 32.8% | 1 | 247 736 086 | -11.8% | 44.6% | 0.1 | -12.0% |
| REDUXIN FORTE | 13 691 | -8.3% | 9.3% | 0.4 | 57 980 483 | -10.1% | 10.4% | 0.2 | -12.0% |
| SALVISAR | 34 936 | -11.1% | 1.1% | -0.2 | 15 667 203 | -7.6% | 1.1% | -0.1 | 2.1% |
ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе “MS of competitors” в блоке каждого бренда
ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the* last full month* and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection “MS of competitors” in sections for each brand
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #90"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #10"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #30"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #60"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #90"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
## [1] "BRAINMAX"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
[RUS] ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе “MS of competitors” в блоке каждого бренда
[ENG] ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the last full month and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection “MS of competitors” in sections for each brand
DATA SOURCES:
DSM: Sales
Palomars: TRPs